§ 211.184. Component, drug product container, closure, and labeling records.
187 words·~1 min read·
/us/cfr/t21/s§ 211.184·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
These records shall include the following:
(a)The identity and quantity of each shipment of each lot of components, drug product containers, closures, and labeling; the name of the supplier; the supplier's lot number(s) if known; the receiving code as specified in § 211.80; and the date of receipt. The name and location of the prime manufacturer, if different from the supplier, shall be listed if known.
(b)The results of any test or examination performed (including those performed as required by § 211.82(a), § 211.84(d), or § 211.122(a)) and the conclusions derived therefrom.
(c)An individual inventory record of each component, drug product container, and closure and, for each component, a reconciliation of the use of each lot of such component. The inventory record shall contain sufficient information to allow determination of any batch or lot of drug product associated with the use of each component, drug product container, and closure.
(d)Documentation of the examination and review of labels and labeling for conformity with established specifications in accord with §§ 211.122(c) and 211.130(c).
(e)The disposition of rejected components, drug product containers, closure, and labeling.